fromwww.scientificamerican.com
11 hours agoA New Drug Slows the Worsening of Type 1 Diabetes and Has Sped up Work on a Full Cure
Teplizumab, a monoclonal antibody approved in 2022, can delay or halt progression of stage 2 type 1 diabetes, extending disease-free years for some patients.